Glenn Hunzinger, PwC's US Health Industries Leader, speaks with Dan Farrell, PwC's Health Services Deals Leader, about the forces shaping health services dealmaking in 2026. Despite ongoing reimbursement uncertainty, rising medical costs, and operational pressures, investors continue to deploy capital into assets with strong fundamentals and clear value crea ... Show More
Jun 25
US Medtech Deals Midyear Outlook 2026: Why companies are investing through uncertainty
Glenn Hunzinger, PwC's US Health Industries Leader, speaks with James Woods, PwC's US MedTech Leader, about the forces shaping MedTech dealmaking in 2026. Despite capital market pressures, supply chain challenges, and geopolitical uncertainty, companies continue to invest in inno ... Show More
12m 21s
Jun 24
US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into Growth
Glenn Hunzinger, PwC's US Health Industries Leader, speaks with Dan Farrell, PwC's Health Services Deals Leader, about the forces shaping health services dealmaking in 2026. Despite ongoing reimbursement uncertainty, rising medical costs, and operational pressures, investors cont ... Show More
13m 55s
Jan 2025
HIMSSCast: How digital health can lower costs, streamline ops and much more
<p>PwC U.S. Health Services Advisory Leader Thom Bales goes into top healthcare challenges, advancements in care delivery, digital health lowering costs, and how health systems should consider addressing diverse patients via digital health.</p>
17m 52s
Sep 2020
Increasing productivity in healthcare: An interview with Allen Karp of Horizon Blue Cross Blue Shield
Read more > Listen to the podcast (duration: 28:51) > In a value-based economic model, payers' strength will be to bring analytic capability, operational capability, technology, and customer relationships to the table. But the care will be delivered and managed at the physician l ... Show More
28m 51s